Antimicrob Agents Chemother Volume 40(4); April 1996

Volume 40(4); April 1996

Research Articles

Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.

T Grebe, R Hakenbeck

Antimicrob Agents Chemother. 1996 April; 40(4): 829–834.

PMCID:: PMC163214

Summary PDF–295K

Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures.

L J Smeijsters, N M Zijlstra, F F Franssen, J P Overdulve

Antimicrob Agents Chemother. 1996 April; 40(4): 835–838.

PMCID:: PMC163215

Summary PDF–183K

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.

G E Zurenko, B H Yagi, R D Schaadt, J W Allison, J O Kilburn, S E Glickman, D K Hutchinson, M R Barbachyn, S J Brickner

Antimicrob Agents Chemother. 1996 April; 40(4): 839–845.

PMCID:: PMC163216

Summary PDF–232K

Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.

A M Thackray, H J Field

Antimicrob Agents Chemother. 1996 April; 40(4): 846–851.

PMCID:: PMC163217

Summary PDF–217K

Na+/H+ antiport activity conferred by Bacillus subtilis tetA(L), a 5' truncation product of tetA(L), and related plasmid genes upon Escherichia coli.

J Cheng, K Baldwin, A A Guffanti, T A Krulwich

Antimicrob Agents Chemother. 1996 April; 40(4): 852–857.

PMCID:: PMC163218

Summary PDF–222K

Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase beta-subunit gene.

P Gaurivaud, F Laigret, J M Bove

Antimicrob Agents Chemother. 1996 April; 40(4): 858–862.

PMCID:: PMC163219

Summary PDF–291K

Altered peptidoglycan composition in vancomycin-resistant Enterococcus faecalis.

B L de Jonge, S Handwerger, D Gage

Antimicrob Agents Chemother. 1996 April; 40(4): 863–869.

PMCID:: PMC163220

Summary PDF–214K

Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.

D Musso, M Drancourt, S Osscini, D Raoult

Antimicrob Agents Chemother. 1996 April; 40(4): 870–873.

PMCID:: PMC163221

Summary PDF–210K

Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.

B A Brown, R J Wallace, Jr, G Onyi

Antimicrob Agents Chemother. 1996 April; 40(4): 874–878.

PMCID:: PMC163222

Summary PDF–226K

Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.

P Heisig

Antimicrob Agents Chemother. 1996 April; 40(4): 879–885.

PMCID:: PMC163223

Summary PDF–242K

Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.

I Herrera-Insúa, K Jacques-Palaz, B E Murray, R M Rakita

Antimicrob Agents Chemother. 1996 April; 40(4): 886–890.

PMCID:: PMC163224

Summary PDF–201K

Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.

G V Doern, M J Ferraro, A B Brueggemann, K L Ruoff

Antimicrob Agents Chemother. 1996 April; 40(4): 891–894.

PMCID:: PMC163225

Summary PDF–188K

Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.

R F Jacobs, S L Kaplan, G E Schutze, A S Dajani, R J Leggiadro, C S Rim, S K Puri

Antimicrob Agents Chemother. 1996 April; 40(4): 895–898.

PMCID:: PMC163226

Summary PDF–190K

Effects of inhibitors of protein synthesis on lysis of Escherichia coli induced by beta-lactam antibiotics.

D G Rodionov, E E Ishiguro

Antimicrob Agents Chemother. 1996 April; 40(4): 899–903.

PMCID:: PMC163227

Summary PDF–182K

Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa.

R White, L Friedrich, D Burgess, D Warkentin, J Bosso

Antimicrob Agents Chemother. 1996 April; 40(4): 904–908.

PMCID:: PMC163228

Summary PDF–219K

Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa.

N Masuda, N Gotoh, S Ohya, T Nishino

Antimicrob Agents Chemother. 1996 April; 40(4): 909–913.

PMCID:: PMC163229

Summary PDF–249K

Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance.

S Gassis, P K Rathod

Antimicrob Agents Chemother. 1996 April; 40(4): 914–919.

PMCID:: PMC163230

Summary PDF–230K

Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.

S Koyano, T Suzutani, I Yoshida, M Azuma

Antimicrob Agents Chemother. 1996 April; 40(4): 920–923.

PMCID:: PMC163231

Summary PDF–183K

Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus.

G L Archer, J A Thanassi, D M Niemeyer, M J Pucci

Antimicrob Agents Chemother. 1996 April; 40(4): 924–929.

PMCID:: PMC163232

Summary PDF–309K

Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods.

K Weiss, M Laverdière, R Rivest

Antimicrob Agents Chemother. 1996 April; 40(4): 930–933.

PMCID:: PMC163233

Summary PDF–176K

The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes.

M Kloppenburg, B M Brinkman, H H de Rooij-Dijk, A M Miltenburg, M R Daha, F C Breedveld, B A Dijkmans, C Verweij

Antimicrob Agents Chemother. 1996 April; 40(4): 934–940.

PMCID:: PMC163234

Summary PDF–358K

Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.

E Azoulay-Dupuis, P Moine, J P Bedos, V Rieux, E Vallee

Antimicrob Agents Chemother. 1996 April; 40(4): 941–946.

PMCID:: PMC163235

Summary PDF–247K

Microtubule inhibitors: structure-activity analyses suggest rational models to identify potentially active compounds.

H L Callahan, C Kelley, T Pereira, M Grogl

Antimicrob Agents Chemother. 1996 April; 40(4): 947–952.

PMCID:: PMC163236

Summary PDF–231K

Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine.

H K Medlin, Y Q Zhu, K M Remington, T R Phillips, T W North

Antimicrob Agents Chemother. 1996 April; 40(4): 953–957.

PMCID:: PMC163237

Summary PDF–191K

Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.

H Vinh, J Wain, T N Vo, N N Cao, T C Mai, D Bethell, T T Nguyen, S D Tu, M D Nguyen, N J White

Antimicrob Agents Chemother. 1996 April; 40(4): 958–961.

PMCID:: PMC163238

Summary PDF–175K

Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.

W T Hughes, J Killmar

Antimicrob Agents Chemother. 1996 April; 40(4): 962–965.

PMCID:: PMC163239

Summary PDF–167K

Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

H J Bootsma, H van Dijk, J Verhoef, A Fleer, F R Mooi

Antimicrob Agents Chemother. 1996 April; 40(4): 966–972.

PMCID:: PMC163240

Summary PDF–332K

Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.

S Merali, A B Clarkson, Jr

Antimicrob Agents Chemother. 1996 April; 40(4): 973–978.

PMCID:: PMC163241

Summary PDF–201K

Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats.

A Jacolot, M Tod, O Petitjean

Antimicrob Agents Chemother. 1996 April; 40(4): 979–982.

PMCID:: PMC163242

Summary PDF–178K

Population pharmacokinetic study of isepamicin with intensive care unit patients.

M Tod, C Padoin, C Minozzi, J Cougnard, O Petitjean

Antimicrob Agents Chemother. 1996 April; 40(4): 983–987.

PMCID:: PMC163243

Summary PDF–184K

Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts.

H Takatani, H Soda, M Fukuda, M Watanabe, A Kinoshita, T Nakamura, M Oka

Antimicrob Agents Chemother. 1996 April; 40(4): 988–991.

PMCID:: PMC163244

Summary PDF–201K

Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

L Wondrack, M Massa, B V Yang, J Sutcliffe

Antimicrob Agents Chemother. 1996 April; 40(4): 992–998.

PMCID:: PMC163245

Summary PDF–236K

Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.

H Frasa, B Benaissa-Trouw, L Tavares, K van Kessel, W Hustinx, J Schellekens, K Kraaijeveld, J Verhoef

Antimicrob Agents Chemother. 1996 April; 40(4): 999–1004.

PMCID:: PMC163246

Summary PDF–197K

Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children.

L Pacifico, F Scopetti, A Ranucci, M Pataracchia, F Savignoni, C Chiesa

Antimicrob Agents Chemother. 1996 April; 40(4): 1005–1008.

PMCID:: PMC163247

Summary PDF–175K

Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.

D J Griggs, K Gensberg, L J Piddock

Antimicrob Agents Chemother. 1996 April; 40(4): 1009–1013.

PMCID:: PMC163248

Summary PDF–211K

Oligonucleotide probes for detection of cephalosporinases among Bacteroides strains.

P Mastrantonio, R Cardines, P Spigaglia

Antimicrob Agents Chemother. 1996 April; 40(4): 1014–1016.

PMCID:: PMC163249

Summary PDF–171K

Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates.

S Safrin, E Palacios, B J Leahy

Antimicrob Agents Chemother. 1996 April; 40(4): 1017–1019.

PMCID:: PMC163250

Summary PDF–154K

Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.

T Deguchi, M Yasuda, M Nakano, S Ozeki, T Ezaki, I Saito, Y Kawada

Antimicrob Agents Chemother. 1996 April; 40(4): 1020–1023.

PMCID:: PMC163251

Summary PDF–183K

Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities.

S Sreevatsan, X Pan, K E Stockbauer, D L Williams, B N Kreiswirth, J M Musser

Antimicrob Agents Chemother. 1996 April; 40(4): 1024–1026.

PMCID:: PMC163252

Summary PDF–162K

Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

M J Soilleux, A M Morand, G J Arlet, M R Scavizzi, R Labia

Antimicrob Agents Chemother. 1996 April; 40(4): 1027–1029.

PMCID:: PMC163253

Summary PDF–179K

Macrolide susceptibility of Mycoplasma hyorhinis isolated from piglets.

H Kobayashi, T Morozumi, G Munthali, K Mitani, N Ito, K Yamamoto

Antimicrob Agents Chemother. 1996 April; 40(4): 1030–1032.

PMCID:: PMC163254

Summary PDF–176K

Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.

L E Bermudez, P Kolonoski, L S Young

Antimicrob Agents Chemother. 1996 April; 40(4): 1033–1035.

PMCID:: PMC163255

Summary PDF–164K

Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli.

K O'Hara, K Yamamoto

Antimicrob Agents Chemother. 1996 April; 40(4): 1036–1038.

PMCID:: PMC163256

Summary PDF–152K

In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.

E O Mason, Jr, L B Lamberth, S L Kaplan

Antimicrob Agents Chemother. 1996 April; 40(4): 1039–1040.

PMCID:: PMC163257

Summary PDF–156K

Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.

R C Fernandez, A A Weiss

Antimicrob Agents Chemother. 1996 April; 40(4): 1041–1043.

PMCID:: PMC163258

Summary PDF–190K

Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.

R C Goldman, D Zakula, J O Capobianco, B A Sharpe, J H Griffin

Antimicrob Agents Chemother. 1996 April; 40(4): 1044–1047.

PMCID:: PMC163259

Summary PDF–198K

Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).

G E Kenny, F D Cartwright

Antimicrob Agents Chemother. 1996 April; 40(4): 1048–1049.

PMCID:: PMC163260

Summary PDF–155K

Differential regulation of the mcb and emr operons of Escherichia coli: role of mcb in multidrug resistance.

O Lomovskaya, F Kawai, A Matin

Antimicrob Agents Chemother. 1996 April; 40(4): 1050–1052.

PMCID:: PMC163261

Summary PDF–162K

Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.

H Ohno, H Koga, S Kohno, T Tashiro, K Hara

Antimicrob Agents Chemother. 1996 April; 40(4): 1053–1056.

PMCID:: PMC163262

Summary PDF–192K

Activity of nitric oxide-generating compounds against encephalomyocarditis virus.

E Guillemard, M Geniteau-Legendre, R Kergot, G Lemaire, J F Petit, C Labarre, A M Quero

Antimicrob Agents Chemother. 1996 April; 40(4): 1057–1059.

PMCID:: PMC163263

Summary PDF–182K

GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.

M Stieger, P Angehrn, B Wohlgensinger, H Gmünder

Antimicrob Agents Chemother. 1996 April; 40(4): 1060–1062.

PMCID:: PMC163264

Summary PDF–160K

Letters

In vitro activity of atovaquone against Leishmania chagasi promastigotes.

J A Jernigan, R D Pearson, W A Petri, Jr, M D Rogers

Antimicrob Agents Chemother. 1996 April; 40(4): 1064.

PMCID:: PMC163265

Summary PDF–151K

DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Staphylococcus haemolyticus.

M Yonezawa, M Takahata, N Banzawa-Futakuchi, N Matsubara, Y Watanabe, H Narita, T Matsunaga, H Igarashi, M Kawahara, S Onodera

Antimicrob Agents Chemother. 1996 April; 40(4): 1065–1066.

PMCID:: PMC163266

Summary PDF–162K

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of
American Society for Microbiology (ASM)

PMC Canada | Copyright | Disclaimer

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's Canada Institute for Scientific and Technical Information in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers.